Physician profile
Amy Sternstein
NPI 1134364656
$170.81
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.47 · 2020: $28.22 · 2021: $59.06 · 2022: $72.06.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $25.00 | 2022 | |
| Merck Sharp & Dohme LLC | $24.14 | 2021 | |
| Gilead Sciences, INC. | $20.04 | 2022 | |
| Lilly USA, LLC | $18.50 | 2021 | |
| Cranial Technologies, INC | $16.42 | 2021 | |
| Boston Scientific Corporation | $15.14 | 2022 | |
| Alexion Pharmaceuticals, INC. | $14.93 | 2020 | |
| Phadia US INC. | $13.29 | 2020 | |
| Nestle Healthcare Nutrition INC. | $11.88 | 2022 | |
| Therapeuticsmd, INC. | $11.47 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Sternstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.